US Patent Issued to Ganmab, BioNTech on Sept. 9 for "Antibodies capable of binding to OX40, variants thereof and uses thereof" (Dutch, German Inventors)

Posted On: 2025-09-10

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,258, issued on Sept. 9, was assigned to Ganmab A/S (Valby, Denmark) and BioNTech SE (Mainz, Germany).

"Antibodies capable of binding to OX40, variants thereof and uses thereof" was invented by Kristel Kemper (Utrecht, Netherlands), Maarten van der Kroef (Utrecht, Netherlands), Dennis Verzijl (Utrecht, Netherlands), Andrea Gorlani (Utrecht, Netherlands), Pauline Linda de Goeje (Utrecht, Netherlands), Lars Guelen (Utrecht, Netherlands), David Satijn (Utrecht, Netherlands), Esther C. W. Breij (Utrecht, Netherlands), Ugur Sahin (Mainz, Germany), Sina Fellermeier-Kopf (Mainz, Germany) and Maren Kohne (Mainz, Germany).

According to the abstract* released by the U.S. Patent & Trademark...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

US Patent Issued to Ganmab, BioNTech on Sept. 9 for "Antibodies capable of binding to OX40, variants thereof and uses thereof" (Dutch, German Inventors)